Neoplasia/BPH

	Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma. EMBO Mol Med Jonsson G, Oliveira T, Hofmann M, Lemberger U, Stejskal K, Kr, Sakic I, Novatchkova M, Mereiter S, Grabmann G, Köcher T, Koglgruber R, Kikic Z, Camano Páez S, Luna Sanchez B, Díez Nicolás V, Rechberger GN, Züllig T, Hagelkruys A, Englinger B, Schmidinger M, Penninger JM. PMID: 42581140 [PubMed - as supplied by publisher]
	Prostate cancer: evading immunity, inspiring therapy. Trends Cancer Calì B, Brina D, Moscarda V, Kohl A, Cetti F, Bressan S, Alimonti A. PMID: 42580969 [PubMed - as supplied by publisher]
	PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study. Eur Urol Quarta L, Zaurito P, Viti A, Cosenza A, Scuderi S, Barletta F, Cucchiara V, Stabile A, Dambrosio L, Mazzone E, Tenace N, Brembilla G, De Cobelli F, Gajate AMS, Pini C, Picchio M, Chiti A, Montorsi F, Briganti A, Gandaglia G. PMID: 42580956 [PubMed - as supplied by publisher]
	Expanding indications for PARP inhibitors in prostate cancer. Urol Oncol Kowalewski HS, Wessels F, Banna GL, Gandur Quiroga MN, Zschäbitz S. PMID: 42580914 [PubMed - as supplied by publisher]
	Re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-412. Eur Urol Oncol Scilipoti P, Rosiello G, Salonia A, Briganti A, Moschini M, Montorsi F. PMID: 42580902 [PubMed - as supplied by publisher]
	Diagnostic and prognostic outcomes for men with prostate cancer detected through opportunistic, asymptomatic PSA testing or symptomatic presentation to primary care: The PC3 cohort study. Br J Gen Pract Merriel S, Nickol P, Abel GA, Hamilton W. PMID: 42580815 [PubMed - as supplied by publisher]
	MR Imaging-Guided Cryoablation of Small Renal Masses. Magn Reson Imaging Clin N Am Awad A, Ahrar K, Stafford J, Abdelsalam ME. PMID: 42579738 [PubMed - indexed for MEDLINE]
	Hereditary Renal Cell Carcinoma: An Imaging Update. Magn Reson Imaging Clin N Am Wang MX, Diab M, Klekers AR, Elsayes KM. PMID: 42579732 [PubMed - indexed for MEDLINE]
	Update on MR Imaging of Cystic and Solid Renal Masses: An Evidence-Based Review. Magn Reson Imaging Clin N Am Frank RA, Krishna S, Schieda N, McGrath TA. PMID: 42579731 [PubMed - indexed for MEDLINE]
	Chemical Shift MR Imaging of Adrenal and Renal Masses. Magn Reson Imaging Clin N Am Wentland AL, Elsayes KM, Schieda N. PMID: 42579728 [PubMed - indexed for MEDLINE]
	Safety and effectiveness of robot-assisted partial nephrectomy in ambulatory mode: a single-center retrospective cohort study. J Robot Surg Liu X, Tai Y, Yao X, Shang J. PMID: 42579266 [PubMed - indexed for MEDLINE]
	Open vs. robotic prostatectomy using Versius(Â®): perioperative, oncologic & learning curve outcomes. J Robot Surg Hammadeh BM, Abuhamad M, Ghanem R. PMID: 42579233 [PubMed - indexed for MEDLINE]
	Single-port vs. multi-port robotic radical prostatectomy: an umbrella review of meta-analyses. J Robot Surg Kumar L, Pal AK, Yuan Y, Ghorai RP, Kishore TA, Khairnar MR, Burton E, Sidana A, Saini S. PMID: 42579231 [PubMed - indexed for MEDLINE]
	Big Data Analytics in Urologic Oncology: A Comprehensive Review of Large-scale Database Research and Clinical Applications. Curr Urol Rep Bourgi A, Rusch E, Bigot P, Bruyère F. PMID: 42579222 [PubMed - indexed for MEDLINE]
	Frailty and comorbidity surpass probable sarcopenia in predicting survival of mCRPC patients treated with first-line ARPIs: a comprehensive geriatric analysis. World J Urol Cheng YL, Kao CC, Meng E, Cha TL, Tsai YT, Tsao CW, Yang MH. PMID: 42578984 [PubMed - indexed for MEDLINE]
	CTCAE-Guided Management of Cytotoxic Chemotherapy Toxicity in Uro-Oncology: A Contemporary Narrative Review. Acta Medica (Hradec Kralove) Tranová MN, Izmaylov O, Princlová H, Navrátil P. PMID: 42578385 [PubMed - indexed for MEDLINE]
	De-escalation surgery for localized prostate cancer: rationale and future direction of precision prostatectomy. Curr Opin Urol Franke J, Rogers CG, Zuluaga L, Badani K, Menon M. PMID: 42578299 [PubMed - indexed for MEDLINE]
	Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges. Int J Nanomedicine Wang J, Zhang Z, Li H, Teng Y, Chen B, Zuo J, Li X, Zhan P, Fu S, Xu Y, Wen L, Wang B, Fu Y, Qin K, Chen W, Huang Y, Shi Y, Chen J, Zhao J. PMID: 42577912 [PubMed - indexed for MEDLINE]
	Deep learning model based on CT images to predict Ki-67 expression in renal carcinoma. Oncol Lett Shen D, Li H, Shi B, Ma T, Zhou B, Gao C, Liu Y, Cui Z. PMID: 42577766 [PubMed]
	First-line immune checkpoint inhibitor plus anti-angiogenic therapy for advanced renal cell carcinoma: a meta-analysis of randomized controlled trials. Front Pharmacol Liu Z, Jiang Y, Zhang Z, Liu J. PMID: 42577666 [PubMed]

Articles 1 - 20 / 190409

Page 1 of 9521



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy